跳至主要内容
临床试验/NCT03044925
NCT03044925Unknown不适用

Remote Magnetic Navigation-guided Ablation Versus Cryoablation for Persistent Atrial Fibrillation: A Prospective, Controlled Study

Ruijin Hospital0 个研究点目标入组 200 人开始时间: 2016年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
200
主要终点
Clinical efficacy (time to first AF recurrence after blanking period)

研究概览

简要总结

Compare the safety and efficacy of remote magnetic navigation-guided ablation and cryoablation for patients with persistent atrial fibrillation.

详细描述

  1. Compare the efficacy of remote magnetic navigation-guided ablation and cryoablation for patients with persistent atrial fibrillation.
  2. Compare the safety of remote magnetic navigation-guided ablation and cryoablation for patients with persistent atrial fibrillation.
  3. Compare the procedural parameters of remote magnetic navigation-guided ablation and cryoablation for patients with persistent atrial fibrillation.
  4. Compare the effects of amiodarone on recurrence after these two different ablation procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persistent atrial fibrillation (>7d, < 5years)
  • Age 18-75 years
  • Patient is mentally and linguistically able to understand the aim of the trial and to show sufficient compliance in following the trial protocol

排除标准

  • Any previous left atrial ablation or surgery
  • Any cardiac surgery or percutaneous coronary intervention within 3 months prior to enrollment
  • Stroke or transient ischemic attack within 6 months prior to enrollment
  • Myocardial infarction within 3 months prior to enrollment
  • Anteroposterior left atrial diameter > 55 mm

研究组 & 干预措施

Remote magnetic navigation

Experimental

Persistent atrial fibrillation ablation with remote magnetic navigation

干预措施: Remote magnetic navigation (Procedure)

Cryoablation

Active Comparator

Persistent atrial fibrillation ablation with cryoballoon

干预措施: Cryoablation (Procedure)

结局指标

主要结局

Clinical efficacy (time to first AF recurrence after blanking period)

时间窗: one year

the time to first AF recurrence after blanking period (month)

Clinical safety (Any procedure-related complications)

时间窗: one year

Any procedure-related complications

次要结局

  • Procedure time (min)(one week)
  • Time to first cardiovascular hospitalization (month)(one year)
  • QoL of 12 months (Units on a Scale)(one year)
  • X-ray time (min)(one week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Qi Jin

Clinical Professor

Ruijin Hospital

相似试验